338 related articles for article (PubMed ID: 16415877)
1. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent.
Machado FS; Johndrow JE; Esper L; Dias A; Bafica A; Serhan CN; Aliberti J
Nat Med; 2006 Mar; 12(3):330-4. PubMed ID: 16415877
[TBL] [Abstract][Full Text] [Related]
2. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.
Menezes-de-Lima O; Kassuya CA; Nascimento AF; Henriques Md; Calixto JB
Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):123-35. PubMed ID: 16939877
[TBL] [Abstract][Full Text] [Related]
3. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
[TBL] [Abstract][Full Text] [Related]
4. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction.
Filep JG; Khreiss T; József L
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):257-62. PubMed ID: 15979865
[TBL] [Abstract][Full Text] [Related]
5. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.
Romano M; Maddox JF; Serhan CN
J Immunol; 1996 Sep; 157(5):2149-54. PubMed ID: 8757340
[TBL] [Abstract][Full Text] [Related]
6. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity.
Aliberti J; Hieny S; Reis e Sousa C; Serhan CN; Sher A
Nat Immunol; 2002 Jan; 3(1):76-82. PubMed ID: 11743584
[TBL] [Abstract][Full Text] [Related]
7. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils.
Qiu FH; Devchand PR; Wada K; Serhan CN
FASEB J; 2001 Dec; 15(14):2736-8. PubMed ID: 11687510
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of lipoxin A4 receptor by thromboxane A2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo.
Sato Y; Kitasato H; Murakami Y; Hashimoto A; Endo H; Kondo H; Inoue M; Hayashi I
Biomed Pharmacother; 2004; 58(6-7):381-7. PubMed ID: 15271420
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
Chiang N; Arita M; Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
[TBL] [Abstract][Full Text] [Related]
10. 15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation.
Paul-Clark MJ; Van Cao T; Moradi-Bidhendi N; Cooper D; Gilroy DW
J Exp Med; 2004 Jul; 200(1):69-78. PubMed ID: 15238606
[TBL] [Abstract][Full Text] [Related]
11. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis.
Hachicha M; Pouliot M; Petasis NA; Serhan CN
J Exp Med; 1999 Jun; 189(12):1923-30. PubMed ID: 10377187
[TBL] [Abstract][Full Text] [Related]
12. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.
Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Huang MH; Perez-Polo JR; Uretsky BF
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):89-98. PubMed ID: 17259075
[TBL] [Abstract][Full Text] [Related]
13. Interactions between lipoxin A4, the stable analogue 16-phenoxy-lipoxin A4 and leukotriene B4 in cytokine generation by human monocytes.
Andersson P; Serhan CN; Petasis NA; Palmblad J
Scand J Immunol; 2004 Sep; 60(3):249-56. PubMed ID: 15320881
[TBL] [Abstract][Full Text] [Related]
14. Lipoxins in gastric mucosal health and disease.
Wallace JL; de Lima OM; Fiorucci S
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):251-5. PubMed ID: 16024242
[TBL] [Abstract][Full Text] [Related]
15. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.
Chiang N; Takano T; Clish CB; Petasis NA; Tai HH; Serhan CN
J Pharmacol Exp Ther; 1998 Nov; 287(2):779-90. PubMed ID: 9808710
[TBL] [Abstract][Full Text] [Related]
16. Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4 in activated murine macrophages: implications in innate immunity.
Moreno C; Prieto P; Macías Á; Pimentel-Santillana M; de la Cruz A; Través PG; Boscá L; Valenzuela C
J Immunol; 2013 Dec; 191(12):6136-46. PubMed ID: 24249731
[TBL] [Abstract][Full Text] [Related]
17. Lipoxin analogs: novel anti-inflammatory mediators.
Gewirtz A
Curr Opin Investig Drugs; 2005 Nov; 6(11):1112-5. PubMed ID: 16312131
[TBL] [Abstract][Full Text] [Related]
18. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
Takano T; Fiore S; Maddox JF; Brady HR; Petasis NA; Serhan CN
J Exp Med; 1997 May; 185(9):1693-704. PubMed ID: 9151906
[TBL] [Abstract][Full Text] [Related]
19. Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases.
Pouliot M; Serhan CN
J Periodontal Res; 1999 Oct; 34(7):370-3. PubMed ID: 10685363
[TBL] [Abstract][Full Text] [Related]
20. ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis.
Martins V; Valença SS; Farias-Filho FA; Molinaro R; Simões RL; Ferreira TP; e Silva PM; Hogaboam CM; Kunkel SL; Fierro IM; Canetti C; Benjamim CF
J Immunol; 2009 May; 182(9):5374-81. PubMed ID: 19380784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]